title: Antibiogram of multidrug resistant Acinetobacter baumannii isolated from clinical specimens at King Hussein Medical Centre, Jordan: a retrospective analysis.
abstract: This study was conducted to determine the prevalence and the local antibiogram of multidrug-resistant Acinetobacter baumannii isolates in Al-Hussein Hospital at King Hussein Medical Centre in Amman, Jordan. In a retrospective study from January to December 2013, data on 116 non-repetitive positive clinical samples were retrieved from patients' laboratory records. The resistance rates of A. baumannii isolates were high for ceftriaxone, cefotaxime and ticarcillin (100%), ceftazidime, cefepime and piperacillin (98.3%), imipenem (97.4%), piperacillin/tazobactam (96.6%), quinolones (94.8%), ampicillin/sulbactam (89.7%), gentamicin, (87.9%), tobramycin and tetracycline (76.7%) and trimethoprim/sulfamethoxazole (75.9%), but lower for minocycline (26.7%) and colistin (1.7%). A. baumannii in our hospital were highly resistant to all antibiotics, including tigecycline, except for minocycline and colistin which are considered the last resort treatment for multidrug-resistant A. baumannii.
authors: Intensive Care Department, Al-Hussein Hospital, King Hussein Medical Centre, Amman, Jordan.
authors: A
authors: A
authors: Batarseh
authors: Intensive Care Department, Al-Hussein Hospital, King Hussein Medical Centre, Amman, Jordan.
authors: A
authors: A
authors: Al-Sarhan
authors: Department of Microbiology, Princess Iman Centre for Research and Laboratory Science, King Hussein Medical Centre, Amman, Jordan.
authors: M
authors: M
authors: Maayteh
authors: Department of Pharmacy, Al-Hussein Hospital, King Hussein Medical Centre, Amman, Jordan.
authors: S
authors: S
authors: Al-Khatirei
authors: Department of Pharmacy, Al-Hussein Hospital, King Hussein Medical Centre, Amman, Jordan.
authors: M
authors: M
authors: Alarmouti
mesh_terms: D000151:Acinetobacter Infections / Q000188:drug therapy*; D040981:Acinetobacter baumannii / Q000187:drug effects* / Q000302:isolation & purification; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D024881:Drug Resistance, Bacterial; D018432:Drug Resistance, Multiple; D006801:Humans; D007597:Jordan / Q000453:epidemiology; D008826:Microbial Sensitivity Tests; D015995:Prevalence; D012189:Retrospective Studies
chemical_list: D000900:Anti-Bacterial Agents